EL.En. S.p.A.
EL.En. S.p.A.
Your view on ELEAF
Overview
What the company does, where it operates, and who runs it.
About EL.En. S.p.A.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Gabriele Clementi
- Headquarters
- Via Baldanzese 17, Calenzano, FI, IT
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Gabriele Clementi
- Headquarters
- Via Baldanzese 17, Calenzano, FI, IT
EL.En. S.p.A. engages in the research and development, manufacture, distribution, and sale of laser systems in Europe and internationally.
The company offers medical laser equipment for use in the fields of physiotherapy, orthopedics, traumatology, rheumatology, dermatology, sports and rehabilitative medicines, surgery, aesthetics, and art; and laser sources and systems for cutting, welding, marking, and engraving on countless materials.
It also provides laser sources that include liquid, solid, semiconductor, and gas; and after-sales services, such as supplying of spare parts, as well as consulting and technical assistance services. The company was founded in 1981 and is headquartered in Calenzano, Italy.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for EL.En. S.p.A., and the rating behind it. ELEAF last traded at $16.60, 15.4× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for EL.En. S.p.A.. Starting points for EL.En. S.p.A.: P/E 15.4, EPS $0.84, beta 1.12 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for EL.En. S.p.A.. EL.En. S.p.A. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for EL.En. S.p.A.. Trailing twelve-month EPS for EL.En. S.p.A. stands at $0.84. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for EL.En. S.p.A.. EL.En. S.p.A. has reported as a listed company since 2012. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
EL.En. S.p.A. valued side by side against its closest peers. EL.En. S.p.A. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold EL.En. S.p.A., and how their positions are changing. At a $1.33B market value, institutional positions materially move EL.En. S.p.A.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by EL.En. S.p.A. executives and directors. Shares of EL.En. S.p.A. have traded between $8.87 and $16.61 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming EL.En. S.p.A.. EL.En. S.p.A. is a $1.33B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming EL.En. S.p.A.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for EL.En. S.p.A.. Coverage tracks EL.En. S.p.A. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.